Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report)’s share price dropped 8.4% on Monday . The company traded as low as $214.31 and last traded at $213.0560. Approximately 1,469,229 shares changed hands during mid-day trading, a decline of 73% from the average daily volume of 5,344,532 shares. The stock had previously closed at $232.68.
Wall Street Analyst Weigh In
A number of research firms have issued reports on ALAB. Susquehanna upped their price target on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Royal Bank Of Canada raised their price target on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. UBS Group initiated coverage on Astera Labs in a research report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price target on the stock. Morgan Stanley boosted their target price on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Finally, Weiss Ratings raised shares of Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Fifteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average price target of $229.65.
View Our Latest Stock Analysis on Astera Labs
Astera Labs Trading Down 9.1%
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s revenue was up 93.5% compared to the same quarter last year. During the same period last year, the business posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current year.
Insider Activity
In related news, Director Manuel Alba sold 183,000 shares of the stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the completion of the transaction, the director directly owned 319,863 shares of the company’s stock, valued at $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the sale, the chief executive officer owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. This trade represents a 7.39% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,497,338 shares of company stock worth $236,827,957 in the last quarter. 12.50% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Astera Labs
A number of hedge funds have recently added to or reduced their stakes in ALAB. Lido Advisors LLC boosted its position in shares of Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after buying an additional 57 shares during the last quarter. Perigon Wealth Management LLC grew its holdings in shares of Astera Labs by 6.2% in the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after acquiring an additional 73 shares during the period. Clearstead Advisors LLC grew its holdings in shares of Astera Labs by 13.6% in the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after acquiring an additional 76 shares during the period. Sound Income Strategies LLC grew its holdings in shares of Astera Labs by 9.2% in the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after acquiring an additional 76 shares during the period. Finally, Venturi Wealth Management LLC grew its holdings in shares of Astera Labs by 2.6% in the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after acquiring an additional 84 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
